Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when polishing the prose of an Advanced Materials manuscript for Wiley house style, concision, precise materials nomenclature and units, and readability across materials subfields. Polishes language; does not restructure the advance or manage the length budget.
インストールする前に、エージェントに与えられる指示の中身を確認できます。
| Wordy pattern | Tightened |
|---|---|
| "It is worth noting that the material exhibits" | "The material exhibits" |
| "In order to investigate" | "To probe" |
| "We have successfully synthesized" | "We synthesized" (drop "successfully") |
| "Due to the fact that" | "Because" |
| "novel and unprecedented" (stacked novelty claims) | one calibrated claim, tied to the design rule |
| Restating every figure value in prose | interpret the figure; don't transcribe it |
| A background paragraph before the result | one-sentence context, then the advance |
Adv. Mater. abstracts and openings are notorious for hype-word inflation ("novel," "unprecedented," "significantly," "remarkable"). Delete the adjective and let the number and the mechanism carry the claim.
Adv. Mater. is read across materials chemistry, physics, energy, electronics, and biomaterials — a battery reviewer may assess a photovoltaics paper. So:
Before (log-style, hype-stacked, un-benchmarked):
"In this work, a novel and unprecedented material was successfully synthesized via a facile method. It was found that the sample exhibits remarkably enhanced performance, which is significantly higher than previous works and may have great potential for future applications."
After (advance-first, calibrated, benchmarked):
"We report a layered oxide whose expanded interlayer spacing accommodates reversible multivalent intercalation. The resulting cathode delivers 220 mAh g⁻¹ at 1C with 92% capacity retention over 500 cycles — outperforming the best reported oxides of this family (Table 1) — because the spacing suppresses lattice strain during cycling."
What changed: "novel/unprecedented/facile/remarkable/significant" all deleted; the metric arrives with conditions and a benchmark; the mechanism ("spacing suppresses strain") replaces vague "great potential."
【Concision / de-hype pass】done? yes / list
【Nomenclature】abbreviations, formulae, sample names consistent? yes / fix
【Broad readability】opening accessible out-of-subfield? yes / fix
【Interpretation + conditions on every metric】yes / fix
【Claim calibration】matched to evidence? yes / fix
【Next】advmat-length-management (fit format) or advmat-cover-letter
Reference and typesetting conventions are set by Wiley and evolve — verify current Advanced Materials style on the official author page.
まだレビューはありません。使ってみた感想をお寄せください。
概要と使いどころ
Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when drafting an AAAI author response (rebuttal) under the single short character-limited author-feedback window, the no-URL rule, no-new-results guidance, AI-generated-review handling, and the AAAI two-phase review process where Phase-2 papers receive one feedback round before SPC/AC discussion.
日本語の概要は準備中です。原文の説明を表示しています。
Use when preparing an accepted AAAI paper for camera-ready source submission to AAAI Press, including proceedings page limits, two-column template compliance, copyright transfer, purchased extra technical pages, deanonymization, registration, oral or poster presentation, and final public artifact release.
日本語の概要は準備中です。原文の説明を表示しています。
Use when designing or auditing AAAI experiments for the broad-AI program committee, including baselines, ablations, statistical significance, robustness, human evaluation, AI-for-Social-Impact and alignment/safety evidence, compute and cost reporting, and reproducibility-checklist alignment for Phase-1 survival.
日本語の概要は準備中です。原文の説明を表示しています。
Use when positioning an AAAI paper's novelty against archival work, contemporaneous arXiv or workshop papers, and AAAI/IJCAI/NeurIPS/ICML/ICLR neighbors across the broad AI scope, while staying inside AAAI's dual-submission and AI-as-source policy constraints and writing a related-work section legible to non-specialist reviewers.
日本語の概要は準備中です。原文の説明を表示しています。
Use when strengthening an AAAI paper's reproducibility checklist (placed after references), experimental traceability, seed and hyperparameter reporting, compute and cost disclosure, dataset access and licensing, code/data ZIP readiness, and the claim-to-evidence map that Phase-1 reviewers use to judge rigor across AAAI's broad AI scope.
日本語の概要は準備中です。原文の説明を表示しています。